NeuroSense Therapeutics Ltd. Interest Expense On Lease Liabilities
NeuroSense Therapeutics Ltd. (NRSN) reported Interest Expense On Lease Liabilities of $11.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Expense Statement
ifrs-full:InterestExpenseOnLeaseLiabilities · last filed 2024-04-04
| Period end | Interest Expense On Lease Liabilities 6 month | Interest Expense On Lease Liabilities 12 month |
|---|---|---|
| 2023-12-31 | $11.00K 20-F · filed 2024-04-04 | |
| 2022-12-31 | $15.00K 20-F · filed 2024-04-04 | |
| 2022-06-30 | $4.00K 6-K/A · filed 2023-01-19 |